INDICATIONS AND USAGE Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin >=50 mg/m 2. Prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic…
Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including high-dose cisplatin. Efficacy of the 32 mg single dose beyond 24 hours in these patients has not been established. Prevention…
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin >=50 mg/m 2. Prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy…
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin >= 50 mg/m 2. Prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy…
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin >= 50 mg/m 2. Prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy…
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2023. All Rights Reserved.